HOOKIPA Pharma Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Matushansky Igor | Chief Medical Officer | Option Exercise | 26,312 | $0.10 | $2,631 | 54,895 | Dec 17, 2019 |
| BAKER JULIAN | — | Purchase | 72,128 | $14.00 | $1,009,792 | 72,128 | Apr 23, 2019 |
| Redmile Group, LLC | — | C | 999,322 | — | — | 999,322 | Apr 23, 2019 |
| SOFINNOVA CAPITAL VI FCPR | — | C | 916,901 | — | — | 999,357 | Apr 23, 2019 |
| Forbion Capital Fund II Cooperatief U.A. | — | C | 1,146,118 | — | — | 1,843,105 | Apr 23, 2019 |